论文部分内容阅读
内蒙医院、巴盟医院、包头医学院附院、包头第二医院等八个单位的传染病科应邀对内蒙地方病防治研究所提供的低分子腺腺肽做了乙型病毒性肝炎治疗的近期疗效观察,经95例患者治疗结果的分析,初步认为是一较好的治疗药物,现将各医院的观察结果综合如下: 一、病例选择及药物使用方法: 1、病例选择:选择的观察对象均按全国病毒性肝炎1984年郑洲会议制定的“病毒性肝炎的诊断标准”。 2、一般资料:治疗对象的一般情况见表1。
Inner Mongolia Hospital, Bameng Hospital, Baotou Medical College Hospital, Baotou Second Hospital and other eight units of infectious diseases invited to Inner Mongolia Institute of endemic disease to provide low-molecular-weight adenylic peptide hepatitis B treatment done in the near future efficacy Observation, the results of the analysis of the treatment of 95 patients, initially considered to be a better therapeutic drug, now the hospital’s observations are summarized as follows: First, the case selection and drug use methods: 1, case selection: the selected observation object According to the National Viral Hepatitis 1984 Cheng Zhou meeting to develop the “diagnostic criteria for viral hepatitis.” 2, general information: The general situation of the treatment object in Table 1.